| Application no. and date | 18719162.2 (espacenet) (Federated) (European Patent Register), 20180420 | | Patent/reg. no. and date | DK/EP 3612234, 20240313 | | Publication date | 20200226 | | Priority no. and date | GB 201706231, 20170420, GB 201706230, 20170420, GB 201706229, 20170420, GB 201706228, 20170420, GB 201706223, 20170420, GB 201706226, 20170420, GB 201706225, 20170420, GB 201706224, 20170420, GB 201706227, 20170420 | | EP pub. no. and date |
EP 3612234 20200226 | | Effective date | | | Applicant/owner | Medimmune Limited, Milstein Building Granta Park
Cambridge, Cambridgeshire CB21 6GH, GB,
ADC Therapeutics SA, Biopôle
Route de la Corniche 3B
1066 Epalinges, CH | | Applicant ref. no. | | | Inventor | VAN BERKEL, Patricius Hendrikus Cornelis, c/o ADC Therapeutics SA
Biopôle
route de la Corniche 3b
1066 Epalinges, CH,
HARTLEY, John, UCL Cancer Institute
Paul O'Gorman Building
72 Huntley Street
London
Greater London WC1E 6BT, GB,
WUERTHNER, Jens, c/o ADC Therapeutics SA
Biopôle route de la Corniche 3b
1066 Epalinges, CH,
ZAMMARCHI, Francesca, c/o ADC Therapeutics SA
Biopôle route de la Corniche 3b
1066 Epalinges, CH | | Representative | | | Opponent | | | IPC Class | A61K 31/502 (2006.01) , A61K 31/706 (2006.01) , A61K 31/7068 (2006.01) , A61K 45/06 (2006.01) , A61K 47/68 (2017.01) , A61P 35/00 (2006.01) | | Title | COMBINATION THERAPY WITH AN ANTI-AXL ANTIBODY-DRUG CONJUGATE | | Int. application no. | EP2018060209 | | Int. publication no. | WO2018193102 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
